319 related articles for article (PubMed ID: 10891399)
21. Modulation of the cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene by Zac1 through the antagonistic regulators p53 and histone deacetylase 1 in HeLa Cells.
Liu PY; Chan JY; Lin HC; Wang SL; Liu ST; Ho CL; Chang LC; Huang SM
Mol Cancer Res; 2008 Jul; 6(7):1204-14. PubMed ID: 18644983
[TBL] [Abstract][Full Text] [Related]
22. v-Jun stimulates both cdk2 kinase activity and G1/S progression via transcriptional repression of p21 CIP1.
Maclaren A; Clark W; Black EJ; Gregory D; Fujii H; Gillespie DA
Oncogene; 2003 Apr; 22(16):2383-95. PubMed ID: 12717415
[TBL] [Abstract][Full Text] [Related]
23. Down-regulation of c-Fos/c-Jun AP-1 dimer activity by sumoylation.
Bossis G; Malnou CE; Farras R; Andermarcher E; Hipskind R; Rodriguez M; Schmidt D; Muller S; Jariel-Encontre I; Piechaczyk M
Mol Cell Biol; 2005 Aug; 25(16):6964-79. PubMed ID: 16055710
[TBL] [Abstract][Full Text] [Related]
24. Activation of the p21(Waf1/Cip1) promoter by the ets oncogene family transcription factor E1AF.
Funaoka K; Shindoh M; Yoshida K; Hanzawa M; Hida K; Nishikata S; Totsuka Y; Fujinaga K
Biochem Biophys Res Commun; 1997 Jul; 236(1):79-82. PubMed ID: 9223430
[TBL] [Abstract][Full Text] [Related]
25. The cis decoy against the estrogen response element suppresses breast cancer cells via target disrupting c-fos not mitogen-activated protein kinase activity.
Wang LH; Yang XY; Zhang X; Mihalic K; Xiao W; Farrar WL
Cancer Res; 2003 May; 63(9):2046-51. PubMed ID: 12727818
[TBL] [Abstract][Full Text] [Related]
26. The inhibitory activity of a transdominant c-jun mutant fused to the ligand binding domain of the estrogen receptor.
Kim S; Brown PH; Birrer MJ
Oncogene; 1996 Mar; 12(5):1043-53. PubMed ID: 8649795
[TBL] [Abstract][Full Text] [Related]
27. Hepatitis B virus X protein increases expression of p21(Cip-1/WAF1/MDA6) and p27(Kip-1) in primary mouse hepatocytes, leading to reduced cell cycle progression.
Qiao L; Leach K; McKinstry R; Gilfor D; Yacoub A; Park JS; Grant S; Hylemon PB; Fisher PB; Dent P
Hepatology; 2001 Nov; 34(5):906-17. PubMed ID: 11679961
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of human glioblastoma cell growth by WAF1/Cip1 can be attenuated by mutant p53.
Jung JM; Li H; Kobayashi T; Kyritsis AP; Langford LA; Bruner JM; Levin VA; Zhang W
Cell Growth Differ; 1995 Aug; 6(8):909-13. PubMed ID: 8547219
[TBL] [Abstract][Full Text] [Related]
29. Arsenic trioxide phosphorylates c-Fos to transactivate p21(WAF1/CIP1) expression.
Liu ZM; Huang HS
Toxicol Appl Pharmacol; 2008 Dec; 233(2):297-307. PubMed ID: 18822310
[TBL] [Abstract][Full Text] [Related]
30. The AP-1 transcription factor regulates breast cancer cell growth via cyclins and E2F factors.
Shen Q; Uray IP; Li Y; Krisko TI; Strecker TE; Kim HT; Brown PH
Oncogene; 2008 Jan; 27(3):366-77. PubMed ID: 17637753
[TBL] [Abstract][Full Text] [Related]
31. Involvement of MAP kinase-independent protein kinase C signaling pathway in the EGF-induced p21(WAF1/Cip1) expression and growth inhibition of A431 cells.
Toyoda M; Gotoh N; Handa H; Shibuya M
Biochem Biophys Res Commun; 1998 Sep; 250(2):430-5. PubMed ID: 9753647
[TBL] [Abstract][Full Text] [Related]
32. Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiP1.
Somasundaram K; Zhang H; Zeng YX; Houvras Y; Peng Y; Zhang H; Wu GS; Licht JD; Weber BL; El-Deiry WS
Nature; 1997 Sep; 389(6647):187-90. PubMed ID: 9296497
[TBL] [Abstract][Full Text] [Related]
33. Functional activity of ectopically expressed estrogen receptor is not sufficient for estrogen-mediated cyclin D1 expression.
Planas-Silva MD; Donaher JL; Weinberg RA
Cancer Res; 1999 Oct; 59(19):4788-92. PubMed ID: 10519385
[TBL] [Abstract][Full Text] [Related]
34. Cytokine induction of proliferation and expression of CDC2 and cyclin A in FDC-P1 myeloid hematopoietic progenitor cells: regulation of ubiquitous and cell cycle-dependent histone gene transcription factors.
Shakoori AR; van Wijnen AJ; Cooper C; Aziz F; Birnbaum M; Reddy GP; Grana X; De Luca A; Giordano A; Lian JB
J Cell Biochem; 1995 Nov; 59(3):291-302. PubMed ID: 8567748
[TBL] [Abstract][Full Text] [Related]
35. Antisense oligonucleotide of WAF1 gene prevents EGF-induced cell-cycle arrest in A431 cells.
Ohtsubo M; Gamou S; Shimizu N
Oncogene; 1998 Feb; 16(6):797-802. PubMed ID: 9488044
[TBL] [Abstract][Full Text] [Related]
36. Repression of c-fos promoter by MyoD on muscle cell differentiation.
Trouche D; Grigoriev M; Lenormand JL; Robin P; Leibovitch SA; Sassone-Corsi P; Harel-Bellan A
Nature; 1993 May; 363(6424):79-82. PubMed ID: 8386804
[TBL] [Abstract][Full Text] [Related]
37. Transcriptional inhibition of matrix metalloproteinase 9 (MMP-9) activity by a c-fos/estrogen receptor fusion protein is mediated by the proximal AP-1 site of the MMP-9 promoter and correlates with reduced tumor cell invasion.
Crowe DL; Brown TN
Neoplasia; 1999 Oct; 1(4):368-72. PubMed ID: 10935492
[TBL] [Abstract][Full Text] [Related]
38. 17 beta-Estradiol overcomes a G1 block induced by HMG-CoA reductase inhibitors and fosters cell cycle progression without inducing ERK-1 and -2 MAP kinases activation.
Bonapace IM; Addeo R; Altucci L; Cicatiello L; Bifulco M; Laezza C; Salzano S; Sica V; Bresciani F; Weisz A
Oncogene; 1996 Feb; 12(4):753-63. PubMed ID: 8632897
[TBL] [Abstract][Full Text] [Related]
39. Transcriptional repression of the cyclin-dependent kinase inhibitor p21WAF1/CIP1 gene mediated by cis elements present in the 3'-untranslated region.
Rishi AK; Hsu CK; Li XS; Hussain A; Gerald TM; Fontana JA
Cancer Res; 1997 Nov; 57(22):5129-36. PubMed ID: 9371514
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of AP-1 suppresses cervical cancer cell proliferation and is associated with p21 expression.
Maritz MF; van der Watt PJ; Holderness N; Birrer MJ; Leaner VD
Biol Chem; 2011 May; 392(5):439-48. PubMed ID: 21417953
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
